At the Alzheimer’s Association International Conference this past July, Andrew Sproul, PhD, a NYSCF Postdoctoral Associate, presented NYSCF’s latest efforts to understand Alzheimer’s disease. They have...
A team of scientists at The New York Stem Cell Foundation (NYSCF) Laboratory led by Scott Noggle, PhD, NYSCF–Charles Evans Senior Research Fellow for Alzheimer’s Disease,...
New York Stem Cell Foundation, Harvard Stem Cell Institute Announce Joint Effort to Accelerate Drug Discovery NEW YORK, N.Y. (Nov. 17, 2011) — The New York...
NYSCF Fellow Dr. Christopher Fasano recently published a paper in which he was able to create floor plate tissue from human embryonic stem cells (hESCs). This...
The New York Stem Cell Foundation (NYSCF) held its fifth annual spring public outreach event on Thursday, March 25 at The TimesCenter in New York City....
Science, News “The announcement last week that a closely watched phase III clinical trial for Alzheimer’s disease had failed to show a significant effect deals yet...
First appeared in The Huffington Post Nothing would give the millions of people afflicted with heart disease, diabetes, cancer, Parkinson’s disease, Alzheimer’s disease and spinal cord...
The New York Stem Cell Foundation expresses its disappointment in the state of New Jersey for voting “no” on the Stem Cell Research Bond Act ballot...
